Correction for "The crystal structure of sphingosine-1-phosphate in complex with a Fab fragment reveals metal bridging of an antibody and its antigen" (Proceedings of the National Academy of Sciences of the United States of America (2009) 106, 42, (17717-17722) DOI: 10.1073/pnas.0906153106);The crystal structure of sphingosine-1-phosphate in complex with a Fab fragment reveals metal bridging of an antibody and its antigen

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 42, 2009, Pages 17717-17722

  Wojciak, Jonathan M ^a   Zhu, Norman ^b   Schuerenberg, Karen T ^b   Moreno, Kelli ^a   Shestowsky, William S ^a   Hiraiwa, Masao ^a   Sabbadini, Roger ^a   Huxford, Tom ^b  

^a Lpath Inc   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Antibody structure; Calcium; Lipid signaling; X ray crystallography

Indexed keywords

AMINO ACID; AMINOALCOHOL; ANTIGEN; CHELATING AGENT; IMMUNOGLOBULIN F(AB) FRAGMENT; LT 1009; METAL; MONOCLONAL ANTIBODY; SONEPCIZUMAB; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; BIOASSAY; CONTROLLED STUDY; COORDINATION; CRYSTAL STRUCTURE; FEMALE; GEOMETRY; HEAVY CHAIN; HUMAN; HUMAN CELL; HYDROGEN BOND; HYDROPHOBICITY; LIGHT CHAIN; MUTAGENESIS; MUTATION; NONHUMAN; PLASMA SPECTROSCOPY; PRIORITY JOURNAL; SPECTROSCOPY; SURFACE PLASMON RESONANCE SPECTROSCOPY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY COMPLEX; BINDING SITES, ANTIBODY; CALCIUM; CRYSTALLOGRAPHY, X-RAY; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; LYSOPHOSPHOLIPIDS; MICE; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; PROTEIN CONFORMATION; SPHINGOSINE; SURFACE PLASMON RESONANCE;

EID: 70449578266     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0911794106     Document Type: Erratum

References (29)

1. Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: Lessons from sphingolipids. Nat Rev Mol Cell Biol 9:139-150.
2. Takabe K, Paugh SW, Milstien S, Spiegel S (2008) "Inside-out" signaling of sphingosine- 1-phosphate: Therapeutic targets. Pharmacol Rev 60:181-195. (Pubitemid 351962008)
3. Zhang H, et al. (1991) Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J Cell Biol 114:155-167. (Pubitemid 21909788)
4. An S, Goetzl EJ, Lee H (1998) Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate. J Cell Biochem Suppl 30-31:147-157.
5. Maceyka M, Payne SG, Milstien S, Spiegel S (2002) Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta 1585:193-201.
6. Van Brocklyn JR, et al. (1998) Dual actions of sphingosine-1-phosphate: Extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J Cell Biol 142:229-240. (Pubitemid 28341153)
7. Gardell SE, Dubin AE, Chun J (2006) Emerging medicinal roles for lysophospholipid signaling. Trends Mol Med 12:65-75.
8. Visentin B, et al. (2006) Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 9:225-238. (Pubitemid 43357948)
9. O'Brien N, et al. (June 9, 2009) Production and characterization of monoclonal antisphingosine-1-phosphate antibodies. J Lipid Res, 10.1194/jlr.M900048-JLR200.
10. Kabat EA, et al. (1991) Sequences of Proteins of Immunological Interest (National Institutes of Health, Bethesda, MD), 5th Ed.
11. Tsodikov OV, Record MT, Jr, Sergeev YV (2002) Novel computer program for fast exact calculation of accessible and molecular surface areas and average surface curvature. J Comput Chem 23:600-609.
12. Pozharski E, et al. (2005) Diversity in hapten recognition: Structural study of an anti-cocaine antibody M82G2. J Mol Biol 349:570-582. (Pubitemid 40724567)
13. Viadiu H, Aggarwal AK (1998) The role of metals in catalysis by the restriction endonuclease BamHI. Nat Struct Biol 5:910-916. (Pubitemid 28467415)
14. Horton JR, Cheng X (2000) PvuII endonuclease contains two calcium ions in active sites. J Mol Biol 300:1049-1056.
15. 2+-bridging mechanism and phospholipid head group recognition in the membrane-binding protein annexin V. Nat Struct Biol 2:968-974.
16. 2+ bridges the C2 membrane-binding domain of protein kinase Calpha directly to phosphatidylserine. EMBO J 18:6329-6338.
17. Huang M, et al. (2003) Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins. Nat Struct Biol 10:751-756. (Pubitemid 37052415)
18. Roberts VA, Getzoff ED (1995) Metalloantibody design. FASEB J 9:94-100.
19. Trisler K, et al. (2007) A metalloantibody that irreversibly binds a protein antigen. J Biol Chem 282:26344-26353. (Pubitemid 47443775)
20. Zhou T, et al. (2005) Interfacial metal and antibody recognition. Proc Natl Acad Sci USA 102:14575-14580.
21. Landry RC, et al. (2001) Antibody recognition of a conformational epitope in a peptide antigen: Fv-peptide complex of an antibody fragment specific for the mutant EGF receptor, EGFRvIII. J Mol Biol 308:883-893.
22. Otwinowski Z, Minor W (1997) in Macromolecular Crystallography, Part A, eds Carter, CW, Jr, Sweet, RM (Academic, New York), pp 307-326.
23. McCoy AJ, et al. (2007) Phaser crystallographic software. J Appl Crystallogr 40:658-674.
24. Murshudov GN, Vagin AA, Dodson EJ (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D 53:240-255.
25. McRee DE (1999) XtalView/Xfit - A versatile program for manipulating atomic coordinates and electron density. J Struct Biol 125:156-165.
26. Kleywegt GJ, Jones TA (1998) Databases in protein crystallography. Acta Crystallogr D 54:1119-1131.
27. Davis IW, et al. (2007) MolProbity: All-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35:W375-W383.
28. Berman HM, et al. (2000) The Protein Data Bank. Nucleic Acids Res 28:235-242.
29. DeLano WL (2008) The PyMOL Molecular Graphics System. (DeLano Scientific LLC, Palo Alto, CA).